News Details - Moderna
WEBMar 26, 2024 — The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
News Details - Moderna
WEBMar 27, 2024 — Announces positive clinical trial data from three new vaccines against viruses that cause significant burden (Epstein-Barr virus, Varicella-Zoster virus, norovirus) and advances programs toward Phase 3 development. Anticipates U.S. launch of vaccine against RSV following FDA approval and ACIP recommendation in 2024.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 — The updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID ...
News Details - Moderna
WEBSep 11, 2023 — Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines …
News Details - Moderna
WEBJun 10, 2024 — mRNA-1083 comprises components of mRNA-1010, Moderna's vaccine candidate for seasonal influenza, and mRNA-1283, Moderna's next-generation COVID-19 vaccine candidate. Each investigational vaccine has independently demonstrated positive Phase 3 clinical trial results.
Moderna says Covid-flu combination vaccine shows positive …
WEBJun 10, 2024 — Vaccine maker Moderna announced positive late-stage trial results for its Covid-flu combination vaccine. There could be a combined Covid-19 and flu shot in our future, although it won’t be ready...
What to know about Pfizer and Moderna’s latest COVID-19 vaccines
WEBAug 28, 2024 — AUSTIN (KXAN) — COVID-19 cases are on the rise once again, with the number of emergency room visits increasing since May, according to the Center for Disease Control and Prevention. To counter new forms of the virus, FDA approved updated vaccines from both Pfizer and Moderna last week.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
WEBSep 11, 2023 — FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
Pioneering mRNA technology - Moderna
WEBPioneering mRNA technology - Moderna. SPIKEVAX® (COVID-19 Vaccine, mRNA) 2024-2025 Formula is now FDA approved. Learn more. Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine. News.
FDA advisory group recommends Moderna booster for emergency use - NBC News
WEBOct 14, 2021 — A Food and Drug Administration advisory panel voted Thursday to recommend Moderna booster shots for emergency use authorization, bringing millions of people in the U.S. one step closer to being...
Skip to content